Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Locally Advanced Hypopharyngeal Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Eye & ENT Hospital of Fudan University, Shanghai, Shanghai Municipality, China
Study coordinator · +86 02164376425

Study leads

Lei Tao
Principal Investigator
Eye & ENT Hospital of Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Hypopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Harbin, China · Jinan, China

Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients

Head and Neck Cancer · Oropharyngeal Carcinoma · Hypopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE1

Rotterdam, Netherlands

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

Larynx Cancer · Hypopharyngeal Cancer

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States